People are not paying attention, and if I were Leo......
Every week of no news is great news for Kevetrin. We will be dosing Cohort 8 inside of a month, How about 225 mg at cohort 8 of Kevetrin? We received unexpected news of efficacy signals at less than 1/4 of this dosage. The market will not put 2 and 2 together until we get something announced.....so this would appear to be a terrific buy window for savy investors.
If I were Leo and Dr. M, I would not ask anybody for a Board position until we announced some sort of preview or interim results in the Kevetrin trial. This bait will attract the truly big fish or two to bite. I believe Leo is all over this issue.